ICOTF - iCo Therapeutics Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
Currency in CAD. All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development1,420.457808.534558.888592.097
Selling General and Administrative781.282664.814672.2351,619.689
Non Recurring----
Others----
Total Operating Expenses2,201.7391,473.3481,231.1232,211.786
Operating Income or Loss-2,201.739-1,473.348-1,231.123-2,211.786
Income from Continuing Operations
Total Other Income/Expenses Net499.116236.04-258.8416.865
Earnings Before Interest and Taxes-2,201.739-1,473.348-1,231.123-2,211.786
Interest Expense----
Income Before Tax-1,702.623-1,237.308-1,489.923-1,794.921
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-1,702.623-1,237.308-1,489.923-1,794.921
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-1,702.623-1,237.308-1,489.923-1,794.921
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-1,702.623-1,237.308-1,489.923-1,794.921